“…We also found an excess of second primary colorectal cancer and of prostatic cancer following a diagnosis of colorectal cancer (Levi et al, 1993b). Data from several cancer registries (e.g., Connecticut, Hoar et al, 1985; Denmark, Lynge et al, 1985; New South Wales, Australia, McCredie et al, 1997) (predominantly colon, rectum, breast, pancreas, stomach, ovary and endometrium) has been described (Lynch and Smyrk, 1996) as part of hereditary non-polyposis colorectal cancer syndrome, but remains poorly defined (Li, 1996).To (Levi et al, 1993a(Levi et al, , 1997.After exclusion of 484 colorectal cancer cases detected at death or autopsy and of 101 cases whose colorectal cancer was synchronous (i.e., within 2 months) with another cancer, the present series comprised 5,261 colorectal cancers (World Health Organization, 1976; ICD-9 153-4) diagnosed between 1974 and 1994 and 4,300 polyps (adenomatous, ICD-O 8210/0; villous, 8261/1; and mixed type, 8263/0) The present analysis confirms, on the basis of a doubled number of cases (Levi et al, 1993a), that the incidence of cancer of the colon, stomach and, possibly, small intestine (but not rectal cancer) is increased after adenomatous polyp of the large intestine (Atkin et al, 1993;Simons et al, 1992) (Lynch and Smyrk, 1996). On account of limited study power, however, increases of less than 50% for breast, corpus uteri or prostate cannot be ruled out.…”